Patent · US Active

Dosage regimen of paliperidone palmitate extended-release injectable suspension

US11666573B2 · kind B2 · utility

0Cited by

3References

17Claims

0Family size

Assignee

Geneora Pharma (Shijiazhuang) Co., Ltd. · CN

Inventors

Youxin Li · Langenfeld, DE
Chunjie Sha · Shandong, CN
Fengjuan Zhao · Shandong, CN
Changbing Tu · Shandong, CN
Kaoxiang Sun · Yantai, CN
Wanhui Liu · Yantai, CN
Lifang Sun · Tianjin, CN
Ying Meng · Shandong, CN

Key dates

Filing date	Oct 26, 2018
Grant date	Jun 6, 2023
Priority date	—
Expiry date	Sep 24, 2039

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are simplified dosing regimens for administering paliperidone palmitate to a patient in need of treatment of schizophrenia or schizoaffective disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.